| Leman Cardiovascular is a biomedical device company founded in late 2004 to develop, manufacture, and market the third generation of heart valves, thereby responding to a market need. We aim to build a worldwide group for cardiovascular surgical devices.
More about Leman Cardiovascular |
 |
| 11/02/2010 |
Morges, Switzerland - Leman Cardiovascular SA the developer of the Kalangos biological heart valve announces that clinical trials in humans will start in Europe in the first quarter of 2010. This is a landmark on the way to achieving CE marking for this new design. Pre-clinical study results have shown superior performance characteristics.
All News |
| |
| |
 |
| 11/02/2010 |
Leman Cardiovascular SA announces start of clinical trials in humans in Q1 2010
Press Releases |
| |
| |
|
